How cell cycle timing shapes senolytic response
Aging - 23-Sep-2025Cells halted in the G2 phase show stronger aging markers and respond better to senolytic drugs
Join the club for FREE to access the whole archive and other member benefits.
Bio-medical journal covering research on all aspects of gerontology
Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan.
The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.
Visit website: https://www.aging-us.com/
Details last updated 30-Aug-2019
Cells halted in the G2 phase show stronger aging markers and respond better to senolytic drugs
This pathway could guide human anti-ageing therapies
We need better clocks before trusting anti-ageing claims
More human trials are needed to confirm anti-ageing effects
Regular exercise helps the body stay biologically younger, suggesting movement is key